Several studies have shown the importance of the gut microbiota in cancer progression and treatment response. Although...
Highlights Articles
Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity
Immunotherapy has revolutionized the treatment of several cancers. However, it remains elusive why only some patients...
Meet Vaiomer at the AFSSI Connexions 2023 – Montpellier
Vaiomer is participating in «la 10e édition des AFSSI Connexions» on July 04 and 05 in MontpellierVaiomer’s...
Resistance to anti-PD-1 immunotherapy can be attributed to the gut microbiome
Immunotherapies (Immune Checkpoint Inhibitors, ICI) have become a powerful therapeutic strategy for treating a variety...
Vaiomer is taking part to « la deuxième édition de LA JOURNÉE DU MICROBIOTE»
Vaiomer is happy to announce its participation to "la deuxième édition de la journée microbiote de MetaGenopolis" on...
Gut microbiota dysbiosis contributes to the tumorigenic process, even in extra-intestinal malignancies
Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the progression and resistance to...
Mouse models with human microbiome
Physiogenex and Vaiomer Launch the TRANSBIOTIC project: A New Collaborative Research Project on mouse models...
Metabolism and obesity: influence of prebiotics, probiotics and symbiotics on microbiomes and liver health
Prebiotic, probiotic and symbiotic treatments affect intestinal and adipose tissue microbiomes, as well as gut and...
Metabolism and Major Depression: Blood microbiome and metabolome exploration
Response to antidepressant is associated with blood microbiome and metabolome of patients with major depressive...